These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29249905)

  • 1. The inodilator levosimendan in repetitive doses in the treatment of advanced heart failure.
    Delgado JF; Oliva F; Reinecke A
    Eur Heart J Suppl; 2017 Mar; 19(Suppl C):C8-C14. PubMed ID: 29249905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive levosimendan treatment in the management of advanced heart failure.
    Oliva F; Comin-Colet J; Fedele F; Fruhwald F; Gustafsson F; Kivikko M; Borbély A; Pölzl G; Tschöpe C
    Eur Heart J Suppl; 2018 Dec; 20(Suppl I):I11-I20. PubMed ID: 30555280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.
    Pölzl G; Altenberger J; Baholli L; Beltrán P; Borbély A; Comin-Colet J; Delgado JF; Fedele F; Fontana A; Fruhwald F; Giamouzis G; Giannakoulas G; Garcia-González MJ; Gustafsson F; Kaikkonen K; Kivikko M; Kubica J; von Lewinski D; Löfman I; Malfatto G; Manito N; Martínez-Sellés M; Masip J; Merkely B; Morandi F; Mølgaard H; Oliva F; Pantev E; Papp Z; Perna GP; Pfister R; Piazza V; Bover R; Rangel-Sousa D; Recio-Mayoral A; Reinecke A; Rieth A; Sarapohja T; Schmidt G; Seidel M; Störk S; Vrtovec B; Wikström G; Yerly P; Pollesello P
    Int J Cardiol; 2017 Sep; 243():389-395. PubMed ID: 28571618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus.
    Nieminen MS; Altenberger J; Ben-Gal T; Böhmer A; Comin-Colet J; Dickstein K; Edes I; Fedele F; Fonseca C; García-González MJ; Giannakoulas G; Iakobishvili Z; Jääskeläinen P; Karavidas A; Kettner J; Kivikko M; Lund LH; Matskeplishvili ST; Metra M; Morandi F; Oliva F; Parkhomenko A; Parissis J; Pollesello P; Pölzl G; Schwinger RH; Segovia J; Seidel M; Vrtovec B; Wikström G
    Int J Cardiol; 2014 Jun; 174(2):360-7. PubMed ID: 24780540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planned repetitive use of levosimendan for heart failure in cardiology and internal medicine in Sweden.
    Thorvaldsen T; Benson L; Hagerman I; Dahlström U; Edner M; Lund LH
    Int J Cardiol; 2014 Jul; 175(1):55-61. PubMed ID: 24820737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure.
    Nieminen MS; Fonseca C; Brito D; Wikström G
    Eur Heart J Suppl; 2017 Mar; 19(Suppl C):C15-C21. PubMed ID: 29249906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of levosimendan in acute heart failure.
    Harjola VP; Giannakoulas G; von Lewinski D; Matskeplishvili S; Mebazaa A; Papp Z; Schwinger RHG; Pollesello P; Parissis JT
    Eur Heart J Suppl; 2018 Dec; 20(Suppl I):I2-I10. PubMed ID: 30555279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis.
    Silvetti S; Nieminen MS
    Int J Cardiol; 2016 Jan; 202():138-43. PubMed ID: 26386941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Levosimendan in Patients with Advanced Heart Failure: An Update.
    Masarone D; Kittleson MM; Pollesello P; Marini M; Iacoviello M; Oliva F; Caiazzo A; Petraio A; Pacileo G
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan: current status and future prospects.
    Archan S; Toller W
    Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Inotropic Agents in Treatment of Systolic Heart Failure.
    Tariq S; Aronow WS
    Int J Mol Sci; 2015 Dec; 16(12):29060-8. PubMed ID: 26690127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT; Paraskevaidis I; Bistola V; Farmakis D; Panou F; Kourea K; Nikolaou M; Filippatos G; Kremastinos D
    Am J Cardiol; 2006 Dec; 98(11):1489-92. PubMed ID: 17126656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inodilator levosimendan as a treatment for acute heart failure in various settings.
    Gustafsson F; Guarracino F; Schwinger RHG
    Eur Heart J Suppl; 2017 Mar; 19(Suppl C):C2-C7. PubMed ID: 29249904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure.
    Bonios MJ; Terrovitis JV; Drakos SG; Katsaros F; Pantsios C; Nanas SN; Kanakakis J; Alexopoulos G; Toumanidis S; Anastasiou-Nana M; Nanas JN
    Int J Cardiol; 2012 Sep; 159(3):225-9. PubMed ID: 21481958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A promising new inotrope: levosimendan.
    Fotbolcu H; Duman D
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):176-82. PubMed ID: 20382619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy.
    Flevari P; Parissis JT; Leftheriotis D; Panou F; Kourea K; Kremastinos DT
    Am J Cardiol; 2006 Dec; 98(12):1641-5. PubMed ID: 17145226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of levosimendan in the treatment of heart failure.
    Lehtonen L; Põder P
    Ann Med; 2007; 39(1):2-17. PubMed ID: 17364447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of levosimendan in patients with heart failure in different settings: case reports and treatment guidance.
    Barbici I; Hedman A; Ewaldsson CA
    Heart Lung Vessel; 2015; 7(2):143-50. PubMed ID: 26157740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent levosimendan infusions in advanced heart failure: a real world experience.
    Ortis B; Villani A; Oldani M; Giglio A; Ciambellotti F; Facchini M; Parati G; Malfatto G
    J Int Med Res; 2017 Feb; 45(1):361-371. PubMed ID: 28222634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsed Levosimendan in advanced heart failure due to congenital heart disease: a case series.
    Cranley J; Hardiman A; Freeman LJ
    Eur Heart J Case Rep; 2020 Jun; 4(3):1-6. PubMed ID: 32617515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.